Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Research on trust in healthcare AI has grown significantly over the last five years, underscoring its vital role in AI adoption within healthcare services. While the multi-dimensional nature of trust in AI is well-documented, the literature lacks an integrative framework to fully understanding its dynamics. This study explores clinicians' perceptions of using AI in breast screening, focusing on the evolving nature of trust in AI within a complex clinical environment. Through thematic analysis of focus groups and interviews with 27 clinicians from the population-based BreastScreen program in Victoria, Australia, we highlight that trust in healthcare AI is fluid and multi-layered. Clinicians considered the broader care context when evaluating the potential of AI in their clinical practice. Their conflicting views coexisted-seeing "AI as an opportunity" to improve service delivery and client experiences and recognizing "uncertainties" surrounding its use. Optimism about AI, framed as opportunity, was tempered by skepticism stemming from factors, such as distrust in AI's performance, uncertainty regarding its role in their clinical practice, personal experiences with AI, and organizational barriers. Ethical, legal, and regulatory considerations also significantly influenced trust. We draw on the framework developed by Stevens and Stetson (2023) to interpret the paradoxical combination of optimism and skepticism observed in our participants. We argue that trust in AI is not a fixed attribute but a dynamic process, shaped by the interplay of technology-related, human-related, and context-related factors. Our findings have practical implications for AI adoption in healthcare.

Download full-text PDF

Source
http://dx.doi.org/10.1177/10497323251351521DOI Listing

Publication Analysis

Top Keywords

trust
8
trust healthcare
8
adoption healthcare
8
nature trust
8
clinical practice
8
trust "fluid
4
"fluid process"
4
process" building
4
building trust
4
trust clinicians'
4

Similar Publications

Comparison of Navier-Stokes and lattice Boltzmann solvers for subject-specific modelling of intracranial aneurysms.

Comput Biol Med

September 2025

INSIGNEO Institute for in silico medicine, University of Sheffield, UK; School of Mechanical, Aerospace and Civil Engineering, University of Sheffield, UK. Electronic address:

Modelling cardiovascular disease is at the forefront of efforts to use computational tools to assist in the analysis and forecasting of an individual's state of health. To build trust in such tools, it is crucial to understand how different approaches perform when applied to a nominally identical scenario, both singularly and across a population. To examine such differences, we have studied the flow in aneurysms located on the internal carotid artery and middle cerebral artery using the commercial solver Ansys CFX and the open-source code HemeLB.

View Article and Find Full Text PDF

Background: Electronic health records (EHRs) are a cornerstone of modern health care delivery, but their current configuration often fragments information across systems, impeding timely and effective clinical decision-making. In gynecological oncology, where care involves complex, multidisciplinary coordination, these limitations can significantly impact the quality and efficiency of patient management. Few studies have examined how EHR systems support clinical decision-making from the perspective of end users.

View Article and Find Full Text PDF

Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

JCO Precis Oncol

September 2025

Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.

Purpose: Tumor comprehensive genomic profiling (CGP) may detect potential germline pathogenic/likely pathogenic (P/LP) alterations as secondary findings. We analyzed the frequency of potentially germline variants and large rearrangements (LRs) in the RATIONAL study, an Italian multicenter, observational clinical trial that collects next-generation sequencing-based tumor profiling data, and evaluated how these findings were managed by the enrolling centers.

Patients And Methods: Patients prospectively enrolled in the pathway-B of the RATIONAL study and undergoing CGP with the FoundationOne CDx assays were included in the analysis.

View Article and Find Full Text PDF

Background: Breast cancer is the most common cancer among women and a leading cause of mortality in Europe. Early detection through screening reduces mortality, yet participation in mammography-based programs remains suboptimal due to discomfort, radiation exposure, and accessibility issues. Thermography, particularly when driven by artificial intelligence (AI), is being explored as a noninvasive, radiation-free alternative.

View Article and Find Full Text PDF